These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31679164)

  • 1. Pre-eclampsia is associated with reduced resolvin D1 and maresin 1 to leukotriene B4 ratios in the plasma.
    Oliveira Perucci L; Pereira Santos TA; Campi Santos P; Ribeiro Teixeira LC; Nessralla Alpoim P; Braga Gomes K; Pires Sousa L; Sant'Ana Dusse LM; Talvani A
    Am J Reprod Immunol; 2020 Feb; 83(2):e13206. PubMed ID: 31679164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal assessment of leukotriene B4, lipoxin A4, and resolvin D1 plasma levels in pregnant women with risk factors for preeclampsia.
    Perucci LO; de Castro Pinto KM; da Silva SPG; Lage EM; Teixeira PG; Barbosa AS; Alpoim PN; de Sousa LP; Talvani A; Dusse LMS
    Clin Biochem; 2021 Dec; 98():24-28. PubMed ID: 34492288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of inflammation in neuromyelitis optica spectrum disorders.
    Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M
    Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Coronary Syndrome May be Associated with Decreased Resolvin D1-to-Leukotriene B4 Ratio.
    Sun C; Zheng W; Liang L; Zhang Z; Liu Z; Sun W; Zhou J; Qiao W; Xie Q; Tang R
    Int Heart J; 2023 Mar; 64(1):22-27. PubMed ID: 36682769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low salivary resolvin D1 to leukotriene B
    Thul S; Labat C; Temmar M; Benetos A; Bäck M
    Eur J Prev Cardiol; 2017 Jun; 24(9):903-906. PubMed ID: 28195518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of human coronary artery plaque is associated with a high ratio of (18-hydroxy-eicosapentaenoic acid + resolvin E1) to leukotriene B
    Welty FK; Schulte F; Alfaddagh A; Elajami TK; Bistrian BR; Hardt M
    FASEB J; 2021 Apr; 35(4):e21448. PubMed ID: 33749913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum leukotriene B4 and hydroxyeicosatetraenoic acid in the prediction of pre-eclampsia.
    Santos LL; Wertaschnigg D; Rolnik DL; Da Silva Costa F; Syngelaki A; Dimitriadis E; Nicolaides KH
    Placenta; 2021 Jan; 103():76-81. PubMed ID: 33099202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of post-lung transplant ischemia-reperfusion injury is modulated via Resolvin D1-FPR2 and Maresin 1-LGR6 signaling.
    Leroy V; Cai J; Tu Z; McQuiston A; Sharma S; Emtiazjoo A; Atkinson C; Upchurch GR; Sharma AK
    J Heart Lung Transplant; 2023 May; 42(5):562-574. PubMed ID: 36628837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype.
    Dalli J; Zhu M; Vlasenko NA; Deng B; Haeggström JZ; Petasis NA; Serhan CN
    FASEB J; 2013 Jul; 27(7):2573-83. PubMed ID: 23504711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS.
    Hartling I; Cremonesi A; Osuna E; Lou PH; Lucchinetti E; Zaugg M; Hersberger M
    Clin Chem Lab Med; 2021 Oct; 59(11):1811-1823. PubMed ID: 34243224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imbalanced serum levels of resolvin E1 (RvE1) and leukotriene B4 (LTB4) in patients with allergic rhinitis.
    Lotfi R; Davoodi A; Mortazavi SH; Gorgin Karaji A; Tarokhian H; Rezaiemanesh A; Salari F
    Mol Biol Rep; 2020 Oct; 47(10):7745-7754. PubMed ID: 32960415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolvin D1 (RvD1) and maresin 1 (Mar1) contribute to human macrophage control of M. tuberculosis infection while resolving inflammation.
    Ruiz A; Sarabia C; Torres M; Juárez E
    Int Immunopharmacol; 2019 Sep; 74():105694. PubMed ID: 31226532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Resolvin D2 to Leukotriene B
    Miao Z; Tang X; Schultzberg M; Zhao Y; Wang X
    Biomed Res Int; 2021; 2021():6657646. PubMed ID: 33728336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of specialized pro-resolving lipid mediators in the regulation of vascular tone and inflammation in human saphenous vein.
    Celik Z; Ozen G; Sunar S; Turkyilmaz S; Turkyilmaz G; Kavala AA; Teskin O; Dogan BSU; Topal G
    Prostaglandins Other Lipid Mediat; 2023 Dec; 169():106786. PubMed ID: 37806440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.
    Kain V; Ingle KA; Colas RA; Dalli J; Prabhu SD; Serhan CN; Joshi M; Halade GV
    J Mol Cell Cardiol; 2015 Jul; 84():24-35. PubMed ID: 25870158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice.
    Viola JR; Lemnitzer P; Jansen Y; Csaba G; Winter C; Neideck C; Silvestre-Roig C; Dittmar G; Döring Y; Drechsler M; Weber C; Zimmer R; Cenac N; Soehnlein O
    Circ Res; 2016 Oct; 119(9):1030-1038. PubMed ID: 27531933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolvin D1, resolvin D2 and maresin 1 activate the GSK3β anti-inflammatory axis in TLR4-engaged human monocytes.
    Gu Z; Lamont GJ; Lamont RJ; Uriarte SM; Wang H; Scott DA
    Innate Immun; 2016 Apr; 22(3):186-95. PubMed ID: 26878867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the maternal serum levels of 19 eicosanoids and pre-eclampsia.
    Long A; Ma S; Li Q; Lin N; Zhan X; Lu S; Zhu Y; Jiang L; Tan L
    Int J Gynaecol Obstet; 2016 Jun; 133(3):291-6. PubMed ID: 27039049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of n-3 fatty acids and coenzyme Q10 supplementation on neutrophil leukotrienes, mediators of inflammation resolution and myeloperoxidase in chronic kidney disease.
    Barden AE; Shinde S; Burke V; Puddey IB; Beilin LJ; Irish AB; Watts GF; Mori TA
    Prostaglandins Other Lipid Mediat; 2018 May; 136():1-8. PubMed ID: 29577973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's Disease and Specialized Pro-Resolving Lipid Mediators: Do MaR1, RvD1, and NPD1 Show Promise for Prevention and Treatment?
    Miyazawa K; Fukunaga H; Tatewaki Y; Takano Y; Yamamoto S; Mutoh T; Taki Y
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32806612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.